- Breakthrough Medical Device Designed to Improve Quality of Life forPatients Suffering From Chronic Diseases
Advertisement
Kingfisher Americas, a healthcare company focused on improving patientquality of life, announced today that Kingfisher Healthcare has filed a U.S.Food and Drug Administration (FDA) 510(k) submission seeking clearance tomarket KFH Energy. The patented, high-tech medical device, designed toalleviate fatigue and pain, was successfully launched in the European marketin September.
Advertisement
KFH Energy is a breakthrough product intended to improve quality of lifefor sufferers of chronic diseases such as post-polio syndrome, fibromyalgia,chronic fatigue syndrome and multiple sclerosis. The device, created for homeuse, utilizes Bio-Electric Stimulation Therapy (BEST) to enhance the body'sphysiological processes at the cellular level. The documented effects includean increase in ATP production, the molecule that delivers energy to all cellsin the body, and increased synthesis of proteins. Kingfisher's KFH Energyencapsulates this unique technology in a convenient and easy-to-use device.
"We are excited to bring this revolutionary healthcare device to theUnited States and are eager to work closely with the FDA for the properapprovals," said Herb Whitaker, CEO of Kingfisher Americas. "The response wehave received in Europe is promising and we look forward to improving thelives of many here in the Americas."
KFH Energy was recently awarded the CE mark in Europe. The companyexpects FDA approval by January 2008.
"The debilitating side effects of such chronic diseases, including polio,have gone untreated for far too long," said Dr. Henk Snyman, founder and CEOof Kingfisher Healthcare, the Belgium-based parent of Kingfisher Americas."We are committed to providing these sufferers with a safe and naturalsolution and look forward to introducing this innovative solution to U.S.patients."
About Kingfisher Americas
Kingfisher Americas, a subsidiary of the Belgium-based KingfisherHealthcare, is committed to providing proprietary natural energy devices andaccessories. It utilizes a technology platform called BEST (Bio-ElectricStimulation Therapy) from which unique products are developed by KingfisherHealthcare. Headquartered in Albuquerque, New Mexico, Kingfisher Americasfocuses on establishing relationships with patients, patient support groups,and medical experts to improve the quality of life of fibromyalgia, postpolio, and chronic fatigue syndrome patients. For more information, pleasevisit http://www.kfamericas.com.
SOURCE Kingfisher Americas
